WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release.
Related articles:
Related suggestion:
China Focus: China Steps up COVIDIn Pics: Closing Ceremony of Beijing 2022 Olympic Winter GamesRailway Workers Prepare for Spring Festival Travel RushSeminar Discusses Gender Equality in Context of Climate Change, Biodiversity LossChina Pledges to Further Support Employment of People Emerging from PovertyChina to Further Open up HighFolk Artists Put on Performance to Celebrate Upcoming Spring Festival in SW China's SichuanIn Pics: Opening Ceremony of 2022 Winter ParalympicsCare Centers in Shandong Provide Assistance and Care to Elderly PeopleLottery Fund
3.1721s , 6604.296875 kb
Copyright © 2024 Powered by FDA brings lab tests under federal oversight in bid to improve accuracy and safety ,International Intricacies news portal